Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor

OBJECTIVES: This study quantified the change in blood pressure (BP) during antivascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) therapy, compared BPs between TKIs, and analyzed change in BP during antihypertensive therapy. BACKGROUND: TKIs targeting VEGF are associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Waliany, Sarah, Sainani, Kristin L., Park, Lesley S., Zhang, Chiyuan Amy, Srinivas, Sandy, Witteles, Ronald M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352203/
https://www.ncbi.nlm.nih.gov/pubmed/34396159
http://dx.doi.org/10.1016/j.jaccao.2019.08.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352203/
https://www.ncbi.nlm.nih.gov/pubmed/34396159
http://dx.doi.org/10.1016/j.jaccao.2019.08.012

Ejemplares similares